Clinical trial NCT03658044: Social Media on Prescription for Colorectal Cancer Patients
Official title: SMOP - Social Media on Prescription, a Randomised Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Colorectal Cancer
Lead sponsor: Sahlgrenska University Hospital
Sponsor class: OTHER
Collaborators: name: Högskolan Väst
First posted: 2018-09-05
Enrollment: 44
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized parallel group study
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The overall aim with this study is to get a deeper understanding of the potential benefits with a health platform for patients diagnosed with colorectal cancer.

Detailed description: This is a prospective randomized parallel group design. Consecutive patients will be recruited from participating hospitals and randomized to either "prescribed participation" or just receiving information about the platform but with no prescription.

All patients are also receiving standard care. After treatment all patients will receive information about the platform and the aim with the platform. A short demonstration of the platform will also be provided. The platform will contain general information on "Life after cancer treatment". It will be a forum to discuss with fellow-patients, both experienced and newly treated and it is also possible to address questions to health professionals. After the demonstration an information about the study will be given and patients will be asked to participate. If accepted a consent form will be presented and signed by the patients. All patients will be given an alias - a username, to be used at the platform which gives the patients confidentiality. However, as this is a research project they will be informed that their clinical data will be extracted from their patient charts. The alias will in a separate file be connected with their personal identification number. The patients randomized to intervention (prescribed participation) will be offered to contact a research nurse or researcher if they have any practical questions regarding the use of the platform. All patients will be asked to answer a questionnaire at baseline, 3, 6 and 12 months after surgery. Patients will be answering the questionnaires electronically on the platform or in a paper version sent by ordinary mail.

Eligibility criteria: Inclusion Criteria:

* Colorectal cancer diagnosis within 1 year
* Must be able to speak and read the Swedish language
* Must be able to use the health platform

Exclusion Criteria:

-Inability to speak and read the Swedish language

Primary outcomes:
measure: Self empowerment measured by Cancer Behavior Inventory (CBI) scale
timeFrame: 12 months
Secondary outcomes:
measure: Self empowerment measured by Cancer Behavior Inventory (CBI) scale
timeFrame: 3 months
measure: Compliance to treatment
timeFrame: 12 months
measure: Quality of life using a Likert scale question tested in several other studies
timeFrame: 12 months
measure: Usability of a health care platform
timeFrame: 12 months
measure: Generated Knowledge in Online Discussions
timeFrame: 3 years
Other outcomes:
Locations:
city: Gothenburg
country: Sweden
facility: Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Study officials:
affiliation: Högskolan Väst
name: Martin Gellerstedt, Ph.D.
role: PRINCIPAL_INVESTIGATOR
affiliation: Sahlgrenska University Hospital
name: Eva Angenete, Ph.D., M.D.
role: PRINCIPAL_INVESTIGATOR
References: